KalVista Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol: KALV on Nasdaq
Industry: Pharmaceutical Preparations
Location: 55 Cambridge Parkway, Suite 901 E, Cambridge, MA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+1.91M	79.2%	$13.69	+$26.1M
Sells	5	-500K	20.8%	$13.22	-$6.61M
Net	-4	+1.41M	58.4%		+$19.5M

KalVista Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Venrock Healthcare Capital Partners III, L.P.	10%+ Owner	$80.9M	+$26.1M	+47.6%	Feb 20, 2024
Benjamin L. Palleiko	CHIEF EXECUTIVE OFFICER, Director	$8.78M	-$1.65M	-15.8%	Sep 6, 2024
Thomas Andrew Crockett	CEO, Director	$4.65M	-$1.87M	-28.7%	Feb 17, 2024
Paul K. Audhya	Chief Medical Officer	$3.05M	-$545K	-15.1%	Aug 22, 2024
Christopher Yea	Chief Development Officer	$2.3M	-$1.07M	-31.8%	Aug 22, 2024
Edward P. Feener	Chief Scientific Officer	$1.2M	-$1.48M	-55.2%	May 17, 2024
Michael David Smith	Senior VP, Development	$127K			May 17, 2022
Brian JG Pereira	Director				Sep 26, 2023
Nancy Stuart	Director				Sep 26, 2023
Daniel B. Soland	Director				Sep 30, 2021
Andreas Maetzel	Senior Vice President, Medical				May 26, 2021
William Fairey	Director				Apr 18, 2024
Edward W. Unkart	Director				Sep 26, 2023
Brian Piekos	Chief Financial Officer				Sep 9, 2024
Albert Cha	Director				Sep 26, 2023
Martin Edwards	Director				Sep 30, 2021
Patrick Treanor	Director				Sep 26, 2023

Recent Insider Transactions by Companies or Individuals for KalVista Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.